macular degeneration

Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer
Xtalks
Wed, 10/27/21 - 10:58 am
Genentech
Roche
ocular implant delivery
macular degeneration
FDA
wet age-related macular degeneration
Regeneron’s golden goose Eylea may stave off biosimilar competition until 2024 or beyond
Endpoints
Tue, 05/4/21 - 10:39 am
Regeneron
Eylea
biosimilars
macular degeneration
Roche, already prepping 2021 launch, charts big expansion plans for Lucentis eye implant
Fierce Pharma
Thu, 09/17/20 - 11:04 pm
Roche
macular degeneration
Lucentis
eye implants
wet age-related macular degeneration
Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug
MedCity News
Fri, 06/26/20 - 07:48 pm
Regeneron
Eylea
Massachusetts
kickbacks
macular degeneration
Adverum Biotechnologies Announces Positive Results in Preclinical Study of ADVM-022 Gene Therapy in Wet AMD
Tue, 05/1/18 - 09:42 am
Adverum Biotechnologies
macular degeneration
wet age-related macular degeneration
Three patients blinded by stem cell procedure, physicians say
Stat
Wed, 03/15/17 - 09:49 pm
US Stem Cell
stem cells
clinical trials
macular degeneration
Healios Aims to Ready Stem-Cell Therapy for Eyesight By 2020
Bloomberg
Tue, 06/23/15 - 10:52 am
Healios
stem cells
macular degeneration
Phase II Calamity Dooms Ohr's Eye Drops
Seeking Alpha
Sun, 06/29/14 - 10:00 am
Squalamine Eye Drops
Ohr Pharmaceutical
macular degeneration
wet age-related macular degeneration
The Lesson of Allergan
TheStreet.com
Tue, 03/18/14 - 11:18 pm
Allergan
DARPin
macular degeneration
Regeneron Pharma raises sales forecast for Eylea
Yahoo/AP
Sat, 05/4/13 - 10:26 am
Regeneron
Eylea
age-related macular degeneration
macular degeneration
Eylea Drives Regeneron
Yahoo/Zacks
Sat, 02/16/13 - 11:17 am
Eylea
Regeneron
macular degeneration
macular edema
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Alimera Sciences shares fall on UK price setback
Yahoo/AP
Sat, 12/1/12 - 09:34 am
Alimera
Iluvien
macular degeneration
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Lpath
Pfizer
iSONEP
Asonept
macular degeneration
multiple sclerosis
MS
Regeneron
Roche
Bayer
Sanofi
Valeant Pharmaceuticals
GSK
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Zolmax
Sun, 10/21/12 - 11:10 am
Ohr Pharmaceutical
macular degeneration
Squalamine Eye Drops
OHR/AVR 118
Cancer Cachexia
Avastin, Lucentis equally effective at improving vision, big study finds
Fierce Pharma
Tue, 05/1/12 - 12:39 pm
Lucentis
Avastin
Roche
Novartis
macular degeneration
Seeing Black Gives Regeneron a 9% Pop
Motley Fool
Sat, 04/28/12 - 11:35 am
Regeneron
Eylea
macular degeneration
Stem Cell Treatment for Eye Diseases Shows Promise
NY Times, NY
Tue, 01/24/12 - 10:49 am
stem cells
blindness
Geron
Advanced Cell Technologies
macular degeneration
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Yahoo/PR NewsWire
Sat, 11/19/11 - 11:36 am
Regeneron
Eylea
macular degeneration
age-related macular degeneration
Stem-Cell Clinical Trials Move Debate Beyond Labs
WSJ Online
Mon, 10/10/11 - 11:04 am
stem cells
Pfizer
macular degeneration

Pages